COVID-19 Vaccination Coverage, and Rates of SARS-CoV-2 Infection and COVID-19-Associated Hospitalization Among Residents in Nursing Homes - National Healthcare Safety Network, United States, October 2023-February 2024

被引:0
|
作者
Franklin, David [1 ,2 ]
Barbre, Kira [1 ,3 ]
Rowe, Theresa A. [1 ]
Reses, Hannah E. [1 ]
Massey, Jason [1 ,4 ]
Meng, Lu [1 ]
Dollard, Philip [1 ]
Dubendris, Heather [1 ,5 ]
Stillions, Molly [1 ]
Robinson, Lindsay [1 ]
Clerville, Jacques W. [1 ,3 ]
Slifka, Kara Jacobs [1 ]
Benin, Andrea [1 ]
Bell, Jeneita M. [1 ]
机构
[1] CDC, Div Healthcare Qual Promot, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA
[2] CACI Int Inc, Reston, VA USA
[3] Goldbelt C6, Chesapeake, VA USA
[4] Chenega Enterprise Syst & Solut LLC, Chesapeake, VA USA
[5] Lantana Consulting Grp, East Thetford, VT USA
来源
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Nursing home residents are at increased risk for developing severe COVID-19. Nursing homes report weekly facilitylevel data on SARS-CoV-2 infections, COVID-19-associated hospitalizations, and COVID-19 vaccination coverage among residents to CDC's National Healthcare Safety Network. This analysis describes rates of incident SARS-CoV-2 infection, rates of incident COVID-19-associated hospitalization, and COVID-19 vaccination coverage during October 16, 2023- February 11, 2024. Weekly rates of SARS-CoV-2 infection ranged from 61.4 to 133.8 per 10,000 nursing home residents. The weekly percentage of facilities reporting one or more incident SARS-CoV-2 infections ranged from 14.9% to 26.1%. Weekly rates of COVID-19-associated hospitalization ranged from 3.8 to 7.1 per 10,000 residents, and the weekly percentage of facilities reporting one or more COVID-19-associated hospitalizations ranged from 2.6% to 4.7%. By February 11, 2024, 40.5% of nursing home residents had received a dose of the updated 2023-2024 COVID-19 vaccine that was first recommended in September 2023. Although the peak rate of SARS-CoV-2 infection among nursing home residents was lower during the 2023-24 respiratory virus season than during the three previous respiratory virus seasons, nursing home residents continued to be disproportionately affected by SARS-CoV-2 infection and related severe outcomes. Vaccination coverage remains suboptimal in this population. Ongoing surveillance for SARS-CoV-2 infections and COVID-19-associated hospitalizations in this population is necessary to develop and evaluate evidence-based interventions for protecting nursing home residents.
引用
收藏
页码:339 / 344
页数:6
相关论文
共 50 条
  • [41] Safety of COVID-19 mRNA vaccination and effects of SARS-CoV-2 infection in children and adults with mast cell disorders
    Catherine K. Zhu
    Alex Nguyen
    Connor Prosty
    Sofianne Gabrielli
    Pasquale Mulé
    Elena Netchiporouk
    Michelle Le
    Xun Zhang
    Greg Shand
    Sharon Baum
    Reman Hakroush
    Shoshana Greenberger
    Ayelet Ollech
    Barbara Miedzybrodzki
    Moshe Ben-Shoshan
    Clinical and Experimental Medicine, 2023, 23 (8) : 4937 - 4942
  • [42] Safety of COVID-19 mRNA vaccination and effects of SARS-CoV-2 infection in children and adults with mast cell disorders
    Zhu, Catherine K.
    Nguyen, Alex
    Prosty, Connor
    Gabrielli, Sofianne
    Mule, Pasquale
    Netchiporouk, Elena
    Le, Michelle
    Zhang, Xun
    Shand, Greg
    Baum, Sharon
    Hakroush, Reman
    Greenberger, Shoshana
    Ollech, Ayelet
    Miedzybrodzki, Barbara
    Ben-Shoshan, Moshe
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (08) : 4937 - 4942
  • [43] Factors Associated with Pre-Vaccination SARS-CoV-2 Infection Risk among Hospital Nurses Facing COVID-19 Outbreak
    Coppeta, Luca
    Ferrari, Cristiana
    Mazza, Andrea
    Trabucco Aurilio, Marco
    Rizza, Stefano
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (24)
  • [44] SARS-CoV-2 infection prevalence and associated factors among primary healthcare workers in France after the third COVID-19 wave
    Marie Pouquet
    Dorine Decarreaux
    Laura Di Domenico
    Chiara E. Sabbatini
    Pol Prévot-Monsacre
    Toscane Fourié
    Paola Mariela Saba Villarroel
    Stephane Priet
    Hélène Blanché
    Jean-Marc Sebaoun
    Jean-François Deleuze
    Clément Turbelin
    Louise Rossignol
    Andréas Werner
    Fabienne Kochert
    Brigitte Grosgogeat
    Pascaline Rabiega
    Julien Laupie
    Nathalie Abraham
    Harold Noël
    Sylvie van der Werf
    Vittoria Colizza
    Fabrice Carrat
    Remi Charrel
    Xavier de Lamballerie
    Thierry Blanchon
    Alessandra Falchi
    Scientific Reports, 14
  • [45] SARS-CoV-2 infection prevalence and associated factors among primary healthcare workers in France after the third COVID-19 wave
    Pouquet, Marie
    Decarreaux, Dorine
    Di Domenico, Laura
    Sabbatini, Chiara E.
    Prevot-Monsacre, Pol
    Fourie, Toscane
    Villarroel, Paola Mariela Saba
    Priet, Stephane
    Blanche, Helene
    Sebaoun, Jean-Marc
    Deleuze, Jean-Francois
    Turbelin, Clement
    Rossignol, Louise
    Werner, Andreas
    Kochert, Fabienne
    Grosgogeat, Brigitte
    Rabiega, Pascaline
    Laupie, Julien
    Abraham, Nathalie
    Noel, Harold
    van der Werf, Sylvie
    Colizza, Vittoria
    Carrat, Fabrice
    Charrel, Remi
    de Lamballerie, Xavier
    Blanchon, Thierry
    Falchi, Alessandra
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [46] Associations between post-acute sequelae of SARS-CoV-2, COVID-19 vaccination and HIV infection: a United States cohort study
    Yendewa, George A.
    Perez, Jaime Abraham
    Patil, Nirav
    McComsey, Grace A.
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [47] COVID-19 Vaccination, Adverse Effect, and SARS-CoV-2 Infection among Couples in Infertility Clinic: A Prospective Study
    Park, Seul Gee
    Kwak, Eunsun
    Kim, Taemi
    Choe, Young June
    Choe, Seung-Ah
    Kim, Jee Hyun
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2023, 50 (12):
  • [48] Susceptibility to SARS-CoV-2 Infection and Immune Responses to COVID-19 Vaccination Among Recipients of Solid Organ Transplants
    Subramanian, Vijay
    JOURNAL OF INFECTIOUS DISEASES, 2023, 228 : S34 - S45
  • [49] SARS-CoV-2 infection after COVID-19 vaccinations among vaccinated individuals, prevention rate of COVID-19 vaccination: A systematic review and meta-analysis
    Dinagde, Dagne Deresa
    Degefa, Bekam Dibaba
    Kitil, Gemeda Wakgari
    Feyisa, Gizu Tola
    Marami, Shambel Negese
    HELIYON, 2024, 10 (09)
  • [50] Assessment of Seroprevalence of SARS-CoV-2 and Risk Factors Associated With COVID-19 Infection Among Outpatients in Virginia
    Rogawski McQuade, Elizabeth T.
    Guertin, Kristin A.
    Becker, Lea
    Operario, Darwin
    Gratz, Jean
    Guan, Dave
    Khan, Fauzia
    White, Jennifer
    McMurry, Timothy L.
    Shah, Bhruga
    Garofalo, Stephanie
    Southerland, Matt
    Bear, Kelly
    Brush, John
    Allen, Cynthia
    Frayser, Amy
    Vokes, Rebecca
    Pershad, Rashmi
    Peake, Lilian
    deFilippi, Christopher
    Barackman, Kathleen
    Bearman, Gonzalo
    Bidanset, Andrea
    Farrell, Francis
    Trump, David
    Houpt, Eric R.
    JAMA NETWORK OPEN, 2021, 4 (02)